International network for ALS research and care (INARC).

The International Network for Amyotrophic Lateral Sclerosis (ALS) Research and Care (INARC) was founded in 2022. INARC's main goals are to offer a platform dedicated to staff members for ALS clinics and research teams who are not physicians. By nurturing experience and expertise exchanges to improve problem solving skills, the ultimate goal is to increase the standard ALS care and research.

Accessing the Pion 3D Structure at US and China Electron-Ion Colliders.

We present the first systematic feasibility study of accessing generalized parton distributions of the pion at an electron-ion collider through deeply virtual Compton scattering. Relying on state-of-the-art models for pion GPDs, we show that quarks and gluons interfere destructively, modulating the expected event rate and maximizing it when parton content is generated via radiation from valence dressed quarks. Moreover, gluons are found to induce a sign inversion for the beam-spin asymmetry in every model studied, being a clear signal for pinning down the regime of gluon superiority.

Enhanced therapeutic index of liposomal doxorubicin Myocet locally delivered by fibrin gels in immunodeficient mice bearing human neuroblastoma.

Caelyx and Myocet are clinically used liposomal forms of doxorubicin (Dox). To explore ways to improve their therapeutic index, we have studied their activity in vitro and in vivo when locally delivered by fibrin gels (FBGs). In vivo local toxic and anti-tumour activities of loaded FBGs were assessed in two immunodeficient mouse orthotopic human neuroblastoma (NB) models after application in the visceral space above the adrenal gland, either still tumour-bearing or after tumour removal.